Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apricitabine Long Term Safety Extension in HIV
NCT00367952Phase 2Completed
- Sponsor
- Avexa Limited
- Start
- Aug 2006
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apricitabine in human immunodeficiency virus infection (HIV), sponsored by Avexa Limited. Started Aug 2006; status: completed.
02
Drugs
apricitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00367952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367952.